id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0002-0057,FDA,FDA-2013-N-0002,Pulmotil AC (aqueous tilmicosin) Environmental Assessment for the Use of Pulmotil AC to Control Swine Respiratory Disease,Other,Background Material,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,,2014-04-09T12:45:38Z,,0,0,09000064816aa8f6
FDA-2013-N-0002-0058,FDA,FDA-2013-N-0002,ENVIRONMENTAL ASSESSMENT for AQUAFLOR (Florfenicol) 50% Type A Medicated Article,Other,Background Material,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,,2014-04-09T12:51:55Z,,0,0,09000064816aa8f7
FDA-2013-N-0002-0056,FDA,FDA-2013-N-0002,"Finding of No Significant Impact FONSI For AQUAFLOR Florfenicol
50 percent Type A Medicated Article",Other,Background Material,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,,2014-04-09T12:40:34Z,,0,0,09000064816aa8f5
FDA-2013-N-0002-0059,FDA,FDA-2013-N-0002,Finding of No Significant Impact (FONSI) for PULMOTIL AC Aqueous Concentrate (Tilmicosin) in Swine for the Control of Swine Respiratory Disease,Other,Background Material,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,,2014-04-09T12:55:59Z,,0,0,09000064816aa8f8
FDA-2013-N-0002-0052,FDA,FDA-2013-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-361
PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate
Swine",Supporting & Related Material,Freedom of Information Summary,2014-04-08T04:00:00Z,2014,4,,,2014-04-08T16:29:38Z,,0,0,09000064816a892c
FDA-2013-N-0002-0053,FDA,FDA-2013-N-0002,"FREEDOM OF INFORMATION SUMMARY  NADA141-420 TILDREN
tiludronate disodium Powder for injection Horse",Supporting & Related Material,Freedom of Information Summary,2014-04-08T04:00:00Z,2014,4,,,2014-04-08T16:32:40Z,,0,0,09000064816a892d
FDA-2013-N-0002-0055,FDA,FDA-2013-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 130-185
AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins",Supporting & Related Material,Freedom of Information Summary,2014-04-08T04:00:00Z,2014,4,,,2014-04-08T16:36:57Z,,0,0,09000064816a8b80
FDA-2013-N-0002-0054,FDA,FDA-2013-N-0002,"FREEDOM OF INFORMATION SUMMARY Application Number 141-422
PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog",Supporting & Related Material,Freedom of Information Summary,2014-04-08T04:00:00Z,2014,4,,,2014-04-08T16:35:08Z,,0,0,09000064816a892e
FDA-2013-N-0002-0051,FDA,FDA-2013-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR
Florfenicol",Supporting & Related Material,Freedom of Information Summary,2014-04-08T04:00:00Z,2014,4,,,2014-04-08T16:22:29Z,,0,0,09000064816a892b
FDA-2013-N-0002-0050,FDA,FDA-2013-N-0002,"New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin;
Florfenicol; Florfenicol and Flunixin; Paclitaxel; Phenylbutazone;
Pimobendan; Salinomycin; Tilmicosin; Tiludronate; Change of Sponsor",Rule,Final Rule,2014-04-01T04:00:00Z,2014,4,2014-04-01T04:00:00Z,,2014-04-01T13:05:54Z,2014-07220,0,0,0900006481694311
FDA-2013-N-0002-0048,FDA,FDA-2013-N-0002,Current Good Manufacturing Practice for Medicated Feeds,Rule,Final Rule,2014-01-23T05:00:00Z,2014,1,2014-01-23T05:00:00Z,,2014-01-23T17:39:42Z,2014-01299,0,0,090000648151cdd1
FDA-2013-N-0002-0047,FDA,FDA-2013-N-0002,"Withdrawal of Approval of New Animal Drug Applications; Argent
Laboratories; Formalin; Tricaine Methanesulfonate",Rule,Final Rule,2014-01-16T05:00:00Z,2014,1,2014-01-16T05:00:00Z,,2014-01-16T15:17:57Z,2014-00721,0,0,090000648150d6c6
FDA-2013-N-0002-0046,FDA,FDA-2013-N-0002,"Withdrawal of Approval of New Animal Drug Applications; Argent
Laboratories; Formalin; Tricaine Methanesulfonate",Rule,Withdrawal,2014-01-16T05:00:00Z,2014,1,2014-01-16T05:00:00Z,,2014-01-16T15:01:12Z,2014-00722,0,0,090000648150d714